Condensed Consolidated Statements of Operations - USD ($) |
3 Months Ended | 12 Months Ended | ||
---|---|---|---|---|
Mar. 31, 2025 |
Mar. 31, 2024 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
Revenue: | ||||
Revenues | $ 587,078 | $ 649,420 | $ 2,566,946 | $ 3,106,026 |
Cost of revenues | 343,003 | 357,958 | 1,437,283 | 1,666,192 |
Gross margin | 244,075 | 291,462 | 1,129,663 | 1,439,834 |
Operating expenses: | ||||
Software development costs | 105,982 | 108,403 | 417,944 | 923,720 |
Selling, general and administrative | 958,521 | 905,929 | 3,568,296 | 5,140,391 |
Advertising and marketing | 65,329 | 132,723 | 436,456 | 629,984 |
Depreciation and amortization | 1,909 | 8,373 | 16,031 | 43,410 |
Total operating expenses | 1,131,741 | 1,155,428 | 4,438,727 | 6,737,505 |
Operating income (loss) | (887,666) | (863,966) | (3,309,064) | (5,297,671) |
Other (income) expense: | ||||
Interest expense | 9,250 | 93 | 263 | 633 |
Financing costs | 81,973 | 0 | 132,308 | 0 |
Amortization of debt issuance costs | 7,790 | 0 | ||
Loss on disposition of assets | 29,940 | 0 | ||
Other income | (157,546) | (348) | 0 | (575,000) |
Investment income | 0 | (348) | (348) | (58,849) |
Total other (income) expense | 58,533 | (255) | 162,163 | (633,216) |
Loss before income taxes | (829,133) | (863,711) | (3,471,227) | (4,664,455) |
Income Taxes | 0 | 0 | 0 | 0 |
Net loss | $ (829,133) | $ (863,711) | $ (3,471,227) | $ (4,664,455) |
Weighted average number of common shares outstanding - basic (in Shares) | 3,549,575 | 3,223,015 | 3,376,407 | 3,219,224 |
Weighted average number of common shares outstanding - diluted (in Shares) | 3,549,575 | 3,223,015 | 3,376,407 | 3,219,224 |
Net loss per share - basic (in Dollars per share) | $ (0.23) | $ (0.27) | $ (1.03) | $ (1.45) |
Net loss per share - diluted (in Dollars per share) | $ (0.23) | $ (0.27) | $ (1.03) | $ (1.45) |
Subscription and Circulation | ||||
Revenue: | ||||
Revenues | $ 562,079 | $ 648,770 | $ 2,563,257 | $ 3,096,112 |
Product and Service, Other | ||||
Revenue: | ||||
Revenues | $ 24,999 | $ 650 | $ 3,689 | $ 9,914 |
X | ||||||||||
- Definition Amount of costs related to financing. No definition available.
|
X | ||||||||||
- Definition Amount of amortization expense attributable to debt issuance costs. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The aggregate cost of goods produced and sold and services rendered during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition Represents the portion of interest incurred in the period on debt arrangements that was charged against earnings, excluding amortization of debt discount (premium) and financing costs. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The total expense recognized in the period for promotion, public relations, and brand or product advertising. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition Amount, after investment expense, of income earned from investments in securities and real estate. Includes, but is not limited to, real estate investment, policy loans, dividends, and interest. Excludes realized gain (loss) on investments. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition Amount of revenue and income classified as other. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition Research and development expense during the period related to the costs of developing and achieving technological feasibility of a computer software product to be sold, leased, or otherwise marketed. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|